Gili Hart

Director/Board Member at ENLIVEX LTD.

Net worth: 6 214 $ as of 31/05/2026

51 year

21 connections

Health Technology

Consumer Services

Health Services

Profile

Gili Hart currently works at SpliSense Ltd., as Chief Executive Officer from 2020, Quicklizard Ltd., as Independent Director from 2021, and Enlivex Therapeutics Ltd., as Independent Director from 2014.
Dr. Hart also formerly worked at OPKO Biologics Ltd., as Chief Executive Officer from 2004 to 2017, Mitoconix Bio Ltd., as Chief Executive Officer from 2017 to 2020, Enlivex Therapeutics Ltd., as Director, CollPlant Biotechnologies Ltd., as Independent Director from 2021 to 2023, OPKO Health, Inc., as Vice President-Biologics, and Prolor Biotech Ltd., as VP-Pre-Clinical & Clinical Pharmacology from 2009 to 2013.
Dr. Hart received her graduate degree and doctorate degree from Weizmann Institute of Science and undergraduate degree from Technion Institute.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ENLIVEX LTD. 0%	18/03/2026	7,672 ( 0% )	6 214 $	31/05/2026

Gili Hart active positions

Companies	Position	Start
ENLIVEX LTD.	Director/Board Member	01/01/2014
QUICKLIZARD LTD	Director/Board Member	21/02/2021
SpliSense Ltd. SpliSense Ltd. Pharmaceuticals: MajorHealth Technology Develops antisense therapeutics for genetic diseases	Chief Executive Officer	01/01/2020

All active positions of Gili Hart

Former positions of Gili Hart

Companies	Position	End
COLLPLANT BIOTECHNOLOGIES LTD.	Director/Board Member	05/07/2023
Mitoconix Bio Ltd. Mitoconix Bio Ltd. BiotechnologyHealth Technology Develops novel therapeutics to improve mitochondrial health as a disease-modifying therapeutics for neurodegenerative diseases	Chief Executive Officer	01/01/2020
OPKO Biologics Ltd. OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins	Chief Executive Officer	01/01/2017
Prolor Biotech Ltd. Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins	Corporate Officer/Principal	01/01/2013
Enlivex Therapeutics Ltd. /Old/ Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions	Director/Board Member	-

See the detail of Gili Hart's experience

Training of Gili Hart

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gili Hart's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
OPKO Biologics Ltd. OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins	Health Technology
Weizmann Institute of Science Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
OPKO Health, Inc. OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics	Health Services
Enlivex Therapeutics Ltd. /Old/ Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions	Health Technology
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices	Health Technology
Technion Institute Technion Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Quicklizard Ltd. Quicklizard Ltd. Packaged SoftwareTechnology Services Develops AI based pricing platform for e-Commerce and Omni channel retailers	Technology Services
Prolor Biotech Ltd. Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins	Health Technology
Mitoconix Bio Ltd. Mitoconix Bio Ltd. BiotechnologyHealth Technology Develops novel therapeutics to improve mitochondrial health as a disease-modifying therapeutics for neurodegenerative diseases	Health Technology
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions	Health Technology
SpliSense Ltd. SpliSense Ltd. Pharmaceuticals: MajorHealth Technology Develops antisense therapeutics for genetic diseases	Health Technology